DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amaryl (Glimepiride) - Current Clinical Trials

 
 



Amaryl Related Clinical Trials

Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition [Completed]

Efficacy/Safety Study of Amaryl«M 1/500 mg Twice Daily Versus Amaryl« 4 mg Both in Combination With Lantus« in Type 2 Diabetes Mellitus [Completed]

Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition [Completed]

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers [Terminated]

Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg [Completed]

Bioequivalence Study of 4 mg Glimepiride Tablet [Completed]

Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg [Completed]

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus [Completed]

Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM [Completed]

Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) [Completed]

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251) [Completed]

ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination [Completed]

TAK-875 Glimepiride Drug-Interaction Study [Completed]

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients [Terminated]

Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus [Completed]

A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016) [Completed]

COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl« M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects. [Not yet recruiting]

Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) [Completed]

Glimepiride 4 mg Tablets Under Fasting Conditions [Completed]

A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027) [Terminated]

Glimepiride 4 mg Tablets Under Non-Fasting Conditions [Completed]

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes [Not yet recruiting]

Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253) [Completed]

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes [Completed]

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ├č -Cell Mass [Completed]

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl«) on Haemoglobin A1c [Terminated]

Food Study of Glimepiride Tablets 1 mg to Amaryl´┐Ż Tablets 1 mg [Completed]

Fasting Study of Glimepiride Tablets 1 mg to Amaryl´┐Ż Tablets 1 mg [Completed]

Study of the Durability of Glycemic Control With Nateglinide [Recruiting]

Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male Volunteers [Completed]

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. [Completed]

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes [Terminated]

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients [Completed]

Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients [Completed]

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects [Completed]

Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin [Recruiting]

Initiation and Titration of Amaryl [Completed]

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride [Completed]

Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia [Completed]

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects [Completed]

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects [Completed]

Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment [Recruiting]

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus [Completed]

Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride [Completed]

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea [Completed]

Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes [Completed]

Drug-drug Interaction Study With ASP1941 and Glimepiride [Completed]

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes [Recruiting]

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002) [Active, not recruiting]

Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM) [Completed]

Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin [Completed]

Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022) [Completed]

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus. [Completed]

Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptinin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea [Not yet recruiting]

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) [Terminated]

Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy [Completed]

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions [Completed]

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions [Completed]

Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride [Recruiting]

A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes [Withdrawn]

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes [Completed]

A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes [Withdrawn]

Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. [Completed]

Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients [Completed]

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan [Completed]

Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus [Recruiting]

A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus [Completed]

Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) [Completed]

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients [Completed]

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) [Completed]

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes [Completed]

Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM [Not yet recruiting]

Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus [Completed]

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione [Completed]

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study [Completed]

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together [Completed]

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes [Not yet recruiting]

A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED) [Completed]

A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Without Control on Metformin Alone [Recruiting]

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled [Completed]

A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes [Withdrawn]

Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR) [Completed]

Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device. [Completed]

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin [Completed]

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus [Completed]

The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY) [Completed]

Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes [Completed]

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate [Completed]

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan [Completed]

START-J: SiTAgliptin in eldeRly Trial in Japan [Completed]

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) [Completed]

A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). [Active, not recruiting]

A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024) [Active, not recruiting]

Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015